Sign In
Buy TWST
$85.00
-0.170 (-0.200%)
At Close: Jun 23, 2026
Ozempic Linked To Lower Risk Of Violence In New Study
11:45am, Wednesday, 17'th Jun 2026
The researchers said the findings are not causal and urged more research into whether GLP-1s reduce the risk of violence. Daniel Semenza, lead author of the study and director of research at the New J
Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.
03:36pm, Friday, 12'th Jun 2026
12,000 shares were exercised from options and sold for a total of ~$673,000 on May 12, 2026. All shares were transacted directly via option exercise and immediate sale; no indirect entities or gifts w
Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?
09:26am, Friday, 12'th Jun 2026
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
02:19pm, Saturday, 06'th Jun 2026
This synthetic biology innovator, known for its DNA-based solutions, reported a notable insider sale amid a year of strong share gains.
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
08:45am, Friday, 05'th Jun 2026
Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to long-term returns.
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million
05:10pm, Thursday, 04'th Jun 2026
This synthetic biology firm, known for silicon-based DNA synthesis, reported a notable insider sale following strong one-year share gains.
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
01:10pm, Tuesday, 02'nd Jun 2026
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
08:00am, Wednesday, 27'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder
Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript
11:07am, Tuesday, 26'th May 2026
Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript
LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery
09:08am, Friday, 08'th May 2026
DÜSSELDORF, Germany--(BUSINESS WIRE)--LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscien
Twist Bioscience: AI Momentum Is Real, But The Easy Money Has Been Made
09:45am, Thursday, 07'th May 2026
Twist Bioscience (TWST) delivered strong Q2 results, driven by AI-enabled drug discovery. NGS growth was soft due to a demand air pocket caused by a large customer. Growth is expected to rebound as th
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
02:36pm, Tuesday, 05'th May 2026
Twist Bioscience Corporation (NASDAQ:TWST) on Monday reported a loss for its fiscal 2026 second quarter.
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:00am, Tuesday, 05'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
01:53pm, Monday, 04'th May 2026
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
01:46pm, Monday, 04'th May 2026
Twist Bioscience Corporation (NASDAQ:TWST) shares are down on Monday as the company reported its fiscal 2026 second-quarter financial results.
